Citation Impact
Citing Papers
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study of the Cortical Spreading Depression Inhibiting Agent Tonabersat in Migraine Prophylaxis
2009
The PHQ-8 as a measure of current depression in the general population
2008 Standout
Anaesthesia, surgery, and challenges in postoperative recovery
2003 Standout
Efficacy and safety of alirocumab, a fully human PCSK9 monoclonal antibody, in high cardiovascular risk patients with poorly controlled hypercholesterolemia on maximally tolerated doses of statins: rationale and design of the ODYSSEY COMBO I and II trials
2014
Prevalence of Depression in the Community from 30 Countries between 1994 and 2014
2018 Standout
Systematic Review and Analysis of Postdischarge Symptoms after Outpatient Surgery
2002
The Economic Costs of Pain in the United States
2012 Standout
Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial
2013
A New Frontier for Headache
2010
The Effect of Improving Primary Care Depression Management on Employee Absenteeism and Productivity
2004 Standout
Lifetime Prevalence of Migraine and Other Headaches Lasting 4 or More Hours: The Atherosclerosis Risk in Communities (ARIC) Study
2004
Relationship Between Burnout and Professional Conduct and Attitudes Among US Medical Students
2010 Standout
The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review
2010 Standout
A six-item short-form survey for measuring headache impact: The HIT-6™
2003
Estimates of Pain Prevalence and Severity in Adults: United States, 2012
2015 Standout
Health-Related Workplace Productivity Measurement: General and Migraine-Specific Recommendations from the ACOEM Expert Panel
2003
Frovatriptan succinate, a 5-HT1B/1D receptor agonist for migraine
2004
Physical and Mental Comorbidity of Headache in a Nationally Representative Sample of US Adults
2008
Efficacy and Safety of Acetaminophen in the Treatment of Migraine
2000
Antidepressants and Cognitive-Behavioral Therapy for Symptom Syndromes
2006
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Calcitonin Gene–Related Peptide Receptor Antagonist BIBN 4096 BS for the Acute Treatment of Migraine
2004 Standout
Clinical Effectiveness and Cost-Effectiveness of Treatments for Patients With Chronic Pain
2002
Non-viral vectors for gene-based therapy
2014 Standout
The Economic Burden of Lost Productivity Due to Migraine Headache: A Specific Worksite Analysis
2002
Migraine Diagnosis and Treatment: Results From the American Migraine Study II
2001
Impact of migraine on patients and their families: the Migraine And Zolmitriptan Evaluation (MAZE) survey – Phase III
2004
Sex, Gender, and Pain: A Review of Recent Clinical and Experimental Findings
2009 Standout
Lost Productive Time and Cost Due to Common Pain Conditions in the US Workforce
2003 Standout
Service use and costs for people with headache: a UK primary care study
2011
Migraine Prevalence and Some Related Factors in Turkey
2004
Acute kidney injury
2021 Standout
A systematic review of low back pain cost of illness studies in the United States and internationally
2008 Standout
In vivo genome editing using Staphylococcus aureus Cas9
2015 StandoutNature
Cost of disorders of the brain in Europe
2005
Consensus Guidelines for the Management of Postoperative Nausea and Vomiting
2013 Standout
Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II
2001 Standout
The World Mental Health (WMH) Survey Initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI)
2004 Standout
Migraine — Current Understanding and Treatment
2002 Standout
The economic cost of brain disorders in Europe
2011 Standout
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Usefulness of the SF-8™ Health Survey for comparing the impact of migraine and other conditions
2003
The Multinational Impact of Migraine Symptoms on Healthcare Utilisation and Work Loss
2001
Anti-diabetic and hypolipidaemic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic rats
2006 Standout
Health-Related Lost Productive Time (LPT): Recall Interval and Bias in LPT Estimates
2004
Cost of Lost Productive Work Time Among US Workers With Depression
2003
Sex differences in the epidemiology, clinical features, and pathophysiology of migraine
2016
The size and burden of mental disorders and other disorders of the brain in Europe 2010
2011 Standout
Botulinum Toxin Type A Prophylactic Treatment of Episodic Migraine: A Randomized, Double‐Blind, Placebo‐Controlled Exploratory Study
2006
Impact of Migraine on the Family: Perspectives of People With Migraine and Their Spouse/Domestic Partner in the CaMEO Study
2016 Standout
Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors
2008 Standout
The Economic Impact of Migraine: An Analysis of Direct and Indirect Costs
2002
Lost Productive Work Time Costs From Health Conditions in the United States: Results From the American Productivity Audit
2003
Workplace Productivity
2001
Health, Absence, Disability, and Presenteeism Cost Estimates of Certain Physical and Mental Health Conditions Affecting U.S. Employers
2004 Standout
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
2015 Standout
Combination therapy in dyslipidemia: Where are we now?
2014
The Global Burden of Headache: A Documentation of Headache Prevalence and Disability Worldwide
2007 Standout
Triptans and CNS Side-Effects
2004
The Epidemiology of Depression Across Cultures
2013 Standout
Non-invasive physical treatments for chronic/recurrent headache
2014
RELIEVING PAIN IN AMERICA: A BLUEPRINT FOR TRANSFORMING PREVENTION, CARE, EDUCATION, AND RESEARCH
2012 Standout
Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review) [RETIRED]
2000 Standout
Therapeutic implications of central and peripheral neurologic mechanisms in migraine
2003
OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial
2010 Standout
Pharmacological interventions for somatoform disorders in adults
2014 Standout
Current Concepts in the Management of Postoperative Nausea and Vomiting
2011
Marine Indole Alkaloids: Potential New Drug Leads for the Control of Depression and Anxiety
2010 Standout
A self-administered screener for migraine in primary care
2003
The cost of migraine and its treatment.
2005
Remaining useful life estimation – A review on the statistical data driven approaches
2010 Standout
Anxiety Disorders in Primary Care: Prevalence, Impairment, Comorbidity, and Detection
2007 Standout
Exercises for mechanical neck disorders
2015 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
A Multicentre, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study of Multiple Treatments of Botulinum Toxin Type A (BoNTA) for the Prophylaxis of Episodic Migraine Headaches
2007
Gelstat Migraine (sublingually administered feverfew and ginger compound) for acute treatment of migraine when administered during the mild pain phase.
2005
Efficacy and Safety of Alirocumab as Add‐on Therapy in High–Cardiovascular‐Risk Patients With Hypercholesterolemia Not Adequately Controlled With Atorvastatin (20 or 40 mg) or Rosuvastatin (10 or 20 mg): Design and Rationale of the ODYSSEY OPTIONS Studies
2014
Two-Zone Proportional Hazard Model for Equipment Remaining Useful Life Prediction
2010
Guidelines for Perioperative Care in Elective Colonic Surgery: Enhanced Recovery After Surgery (ERAS®) Society Recommendations
2012 Standout
Sensitization of the Trigeminovascular Pathway: Perspective and Implications to Migraine Pathophysiology
2012
The Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop
2015 Standout
Guidelines for Perioperative Care in Elective Rectal/Pelvic Surgery: Enhanced Recovery After Surgery (ERAS®) Society Recommendations
2012 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Patterns of health care utilization for migraine in England and in the United States
2003 Standout
Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine
2007
Multispecialty consensus on diagnosis and treatment of headache
2000
Real-time glomerular filtration rate: improving sensitivity, accuracy and prognostic value in acute kidney injury
2020
Work and Productivity Loss in the Rizatriptan Multiple Attack Study
2000
Migraine prevalence, disease burden, and the need for preventive therapy
2007 Standout
Works of Xiaohan Hu being referenced
Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular disease
2013
Subclinical acute kidney injury is associated with adverse outcomes in critically ill neonates and children
2018
Treatment of Migraine With Rizatriptan: When to Take the Medication
2002
Treating Early Versus Treating Mild: Timing of Migraine Prescription Medications Among Patients With Diagnosed Migraine
2005
Times to pain relief and pain freedom with rizatriptan 10 mg and other oral triptans
2007
Burden of Migraine in the United States
1999
Loss of early gains in low-density lipoprotein cholesterol goal attainment among high-risk patients
2010
Postoperative nausea and vomiting following inpatient surgeries in a teaching hospital: a retrospective database analysis
2006